EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LHFPL2 Serves as a Potential Biomarker for M2 Polarization of Macrophages in Renal Cell Carcinoma

Xiaocheng Gong, Yunfei Liu, Qian Zhang, Keying Liang iD, Jinfen Wei, Hongli Du

International Journal of Molecular Sciences · 18.06.2024 · 25 (12) · 6707

DOI: 10.3390/ijms25126707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 18.06.2024. Verfasst von Xiaocheng Gong und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Carcinoma, Renal Cell, Kidney Neoplasms, Macrophages. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, the Key Research and Development Program of Guangdong Province, the China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Renal cell carcinoma (RCC) is one of the most common malignant tumors of the kidney, presenting significant challenges for clinical diagnosis and treatment. Macrophages play crucial roles in RCC, promoting tumor progression and warranting further investigation. Previous studies have identified LHFPL2 as a transmembrane protein associated with reproduction, but its relationship with tumors or macrophages has not been discussed. This study utilized transcriptomic sequencing data from 609 KIRC patients in the TCGA database and single-cell sequencing data from 34,326 renal carcinoma cells for subsequent analysis. We comprehensively evaluated the expression of LHFPL2 and its relationship with clinical features, tumor prognosis, immune infiltration, and mutations. Additionally, we further assessed the correlation between LHFPL2 and macrophage M2 polarization using single-cell data and explored its potential as a cancer therapeutic target through molecular docking. The results demonstrated that LHFPL2 is upregulated in RCC and associated with poor survival rates. In clinical staging, the proportion of malignant and high-metastasis patients was higher in the high-LHFPL2 group than in the low-LHFPL2 group. Furthermore, we found that LHFPL2 influences RCC immune infiltration, with its expression positively correlated with various immune checkpoint and M2-related gene expressions, positively associated with M2 macrophage infiltration, and negatively correlated with activated NK cells. Moreover, LHFPL2 showed specific expression in macrophages, with the high-expression subgroup exhibiting higher M2 polarization, hypoxia, immune evasion, and angiogenesis scores, promoting tumor progression. Finally, we predicted several potential drugs targeting LHFPL2, such as conivaptan and nilotinib. Our analysis elaborately delineates the immune characteristics of LHFPL2 in the tumor microenvironment and its positive correlation with macrophage M2 polarization, providing new insights into tumor immunotherapy. We also propose potential FDA-approved drugs targeting this gene, which should be tested for their binding effects with LHFPL2 in future studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biomarkers, TumorCarcinoma, Renal CellKidney NeoplasmsMacrophagesFemaleHumansMaleGene Expression Regulation, NeoplasticMolecular Docking SimulationPrognosisTumor MicroenvironmentMembrane Proteins

Stichwörter der Autor:innen

LHFPL2M2 polarizationimmune infiltrationmacrophages

Substanzen

Biomarkers, TumorLHFPL2 protein, humanMembrane Proteins

Autor:innen und Institutionen

  • School of Biology and Biological Engineering, South China University of Technology, Guangzhou 510006, China.

ORCID-Profile: Keying Liang

Förderung

  • the National Key Research and Development Program of China
  • the Key Research and Development Program of Guangdong Province
  • the China Postdoctoral Science Foundation
  • the Science and Technology Planning Project of Guangzhou
  • National Key Research and Development Program of China
  • Key Research and Development Program of Guangdong Province
  • China Postdoctoral Science Foundation
  • Science and Technology Planning Project of Guangzhou

Zitieren

APA

Gong, X., Liu, Y., Zhang, Q., Liang, K., Wei, J., & Du, H. (2024). LHFPL2 Serves as a Potential Biomarker for M2 Polarization of Macrophages in Renal Cell Carcinoma. International Journal of Molecular Sciences, 25(12), 6707. https://doi.org/10.3390/ijms25126707

Vancouver

Gong X, Liu Y, Zhang Q, Liang K, Wei J, Du H. LHFPL2 Serves as a Potential Biomarker for M2 Polarization of Macrophages in Renal Cell Carcinoma. International Journal of Molecular Sciences. 2024;25(12):6707. doi:10.3390/ijms25126707

BibTeX
@article{Gong2024,
  author = {Gong, Xiaocheng and Liu, Yunfei and Zhang, Qian and Liang, Keying and Wei, Jinfen and Du, Hongli},
  title = {LHFPL2 Serves as a Potential Biomarker for M2 Polarization of Macrophages in Renal Cell Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {12},
  pages = {6707},
  doi = {10.3390/ijms25126707}
}
Kostenlos starten →